These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11027814)

  • 21. Oncospheral penetration glands are the source of the EG95 vaccine antigen against cystic hydatid disease.
    Jabbar A; Jenkins DJ; Crawford S; Walduck AK; Gauci CG; Lightowlers MW
    Parasitology; 2011 Jan; 138(1):89-99. PubMed ID: 20663253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological responses and potency of the EG95NC
    Jazouli M; Lightowlers MW; Bamouh Z; Gauci CG; Tadlaoui K; Ennaji MM; Elharrak M
    Parasitol Int; 2020 Oct; 78():102149. PubMed ID: 32464256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic polypeptides of Echinococcus granulosus oncospheres and definition of protective molecules.
    Heath DD; Lawrence SB
    Parasite Immunol; 1996 Jul; 18(7):347-57. PubMed ID: 9229388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot Field Trial of the EG95 Vaccine Against Ovine Cystic Echinococcosis in Rio Negro, Argentina: Second Study of Impact.
    Larrieu E; Mujica G; Gauci CG; Vizcaychipi K; Seleiman M; Herrero E; Labanchi JL; Araya D; Sepúlveda L; Grizmado C; Calabro A; Talmon G; Poggio TV; Crowley P; Cespedes G; Santillán G; García Cachau M; Lamberti R; Gino L; Donadeu M; Lightowlers MW
    PLoS Negl Trop Dis; 2015; 9(10):e0004134. PubMed ID: 26517877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host-protective fragments and antibody binding epitopes of the Taenia ovis 45W recombinant antigen.
    Lightowlers MW; Waterkeyn JG; Rothel JS; Gauci CG; Harrison GB
    Parasite Immunol; 1996 Oct; 18(10):507-13. PubMed ID: 9226688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydatid disease: vaccinology and development of the EG95 recombinant vaccine.
    Gauci C; Heath D; Chow C; Lightowlers MW
    Expert Rev Vaccines; 2005 Feb; 4(1):103-12. PubMed ID: 15757477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cloning and sequence analysis of Eg95 cDNA from different stages of Echinococcus granulosus in Xinjiang].
    Lin RY; Ding JB; Wen H; Zhang WB; Li J; Lu XM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(3):170-2. PubMed ID: 14628351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of cystic echinococcosis in the Middle Atlas, Morocco: Field evaluation of the EG95 vaccine in sheep and cesticide treatment in dogs.
    Amarir F; Rhalem A; Sadak A; Raes M; Oukessou M; Saadi A; Bouslikhane M; Gauci CG; Lightowlers MW; Kirschvink N; Marcotty T
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009253. PubMed ID: 33684115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serology and longevity of immunity against Echinococcus granulosus in sheep and llama induced by an oil-based EG95 vaccine.
    Poggio TV; Jensen O; Mossello M; Iriarte J; Avila HG; Gertiser ML; Serafino JJ; Romero S; Echenique MA; Dominguez DE; Barrios JR; Heath D
    Parasite Immunol; 2016 Aug; 38(8):496-502. PubMed ID: 27104482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of the EG95 hydatid vaccine in a macropodid host, the tammar wallaby.
    Barnes TS; Hinds LA; Jenkins DJ; Coleman GT; Colebrook AL; Kyngdon CT; Gauci CG; Lightowlers MW
    Parasitology; 2009 Apr; 136(4):461-8. PubMed ID: 19195411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transient expression of Echinococcus granulosus Eg95 DNA vaccine and induction of immune response in mice].
    Lin RY; Ding JB; Lu XM; Wang XF; Arziguli ; Wei XL; Wang Y; Wen H
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Aug; 22(4):204-8. PubMed ID: 15587152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of recombinant goatpox virus expressing Echinococcus granulosus EG95 vaccine antigen.
    Liu F; Fan X; Li L; Ren W; Han X; Wu X; Wang Z
    J Virol Methods; 2018 Nov; 261():28-33. PubMed ID: 30086380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: 8 years of work.
    Larrieu E; Mujica G; Araya D; Labanchi JL; Arezo M; Herrero E; Santillán G; Vizcaychipi K; Uchiumi L; Salvitti JC; Grizmado C; Calabro A; Talmon G; Sepulveda L; Galvan JM; Cabrera M; Seleiman M; Crowley P; Cespedes G; García Cachau M; Gino L; Molina L; Daffner J; Gauci CG; Donadeu M; Lightowlers MW
    Acta Trop; 2019 Mar; 191():1-7. PubMed ID: 30576624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of a recombinant orf virus that expresses an Echinococcus granulosus vaccine antigen from a novel genomic insertion site.
    Marsland BJ; Tisdall DJ; Heath DD; Mercer AA
    Arch Virol; 2003 Mar; 148(3):555-62. PubMed ID: 12607106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal antibody parameters of cattle and calves receiving EG95 vaccine to protect against Echinococcus granulosus.
    Heath DD; Robinson C; Lightowlers MW
    Vaccine; 2012 Nov; 30(50):7321-6. PubMed ID: 22981849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination with recombinant oncosphere antigens reduces the susceptibility of sheep to infection with Taenia multiceps.
    Gauci C; Vural G; Oncel T; Varcasia A; Damian V; Kyngdon CT; Craig PS; Anderson GA; Lightowlers MW
    Int J Parasitol; 2008 Jul; 38(8-9):1041-50. PubMed ID: 18160069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination with rEGVac elicits immunoprotection against different stages of Echinococcus granulosus life cycle: A pilot study.
    Pourseif MM; Moghaddam G; Nematollahi A; Khordadmehr M; Naghili B; Dehghani J; Omidi Y
    Acta Trop; 2021 Jun; 218():105883. PubMed ID: 33676937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot vaccination project for the control of hydatid disease in Matera province (southern Italy).
    Casulli A; Vitelli G; Santagada G; Pozio E
    Parassitologia; 2004 Dec; 46(4):421. PubMed ID: 16044706
    [No Abstract]   [Full Text] [Related]  

  • 39. Preliminary evaluation of a thermosensitive chitosan hydrogel for Echinococcus granulosus vaccine delivery.
    Umair S; Pernthaner A; Deng Q; Gibson B; Hook S; Heath D
    Vet Parasitol; 2017 Mar; 236():117-120. PubMed ID: 28288754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the eg95 gene family in the G6 genotype of Echinococcus granulosus.
    Alvarez Rojas CA; Gauci CG; Nolan MJ; Harandi MF; Lightowlers MW
    Mol Biochem Parasitol; 2012 Jun; 183(2):115-21. PubMed ID: 22349630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.